PPARG and epilepsy: Furthermore, some studies have suggested that sodium valproate-induced obesity and weight gain might be linked to CD36 and PPARγ polymorphisms, with these genetic factors potentially serving as predictive markers for sodium valproate-induced obesity in Chinese Han epilepsy patients [41].